Tracking therapeutic nanoparticles that target breast tumors

Dec 17, 2010

Researchers at Rice University, collaborating with investigators at the Baylor College of Medicine, have used two different types of imaging technologies to track the delivery of a therapeutic nanoparticle to breast tumors. The results of this study, which appear in the journal Nano Letters, not only demonstrate the ability to create and track multimodal nanoparticles in the body, but also provide valuable information about how targeting agents impact the fate of complex nanoparticles in the body.

This work was led by Naomi Halas at Rice and Amit Joshi at Baylor. Dr. Halas is co-principal investigator of one of 12 Cancer Nanotechnology Platform Partnerships funded by the National Cancer Institute Alliance for Nanotechnology in Cancer. Dr. Joshi is a member of the Texas Center for Cancer , one of nine Centers of Cancer Nanotechnology Excellence funded by the National Cancer Institute Alliance for Nanotechnology in Cancer.

The investigators conducted their studies using a gold nanoshell to which they added a magnetic iron oxide nanoparticles embedded in a thin layer of , followed by a layer of a fluorescent molecule known as ICG and targeting antibody, and finally a layer of polyethylene glycol (PEG) to render the entire construct biocompatible. For targeting , the researchers used an antibody that recognizes the HER2 surface protein found on some forms of .

After injecting this nanoparticle into mice bearing human tumors that overexpress the HER2 protein, the researchers used both near-infrared imaging and magnetic resonance imaging to follow the particles for the next 72 hours. Tumor levels of the nanoparticle peaked at about 4 hours after injection. In contrast, there was little nanoparticle accumulation in tumors when injected into mice bearing tumors that do not overexpress the HER2 protein. The results obtained when the animals were imaged using magnetic resonance imaging differed in that tumor levels did not peak until 24 hours after injection.

The researchers hypothesized that the two results differed because fluorescence imaging detects nanoparticles attached to the outer edge of the tumor while detects nanoparticles distributed throughout the tumor mass. The fact that it takes longer for nanoparticles to diffuse into the core of a tumor than to merely bind to its surface would explain the time discrepancy. Additional experiments confirmed that the nanoparticles remained intact throughout the experiment.

Explore further: New nanodevice defeats drug resistance

More information: This work, which was supported in part by the National Cancer Institute, is detailed in a paper titled "Tracking of Multimodal Therapeutic Nanocomplexes Targeting Breast Cancer in Vivo." An abstract of this paper is available at the journal's website.

Related Stories

Nanoparticles Image Breast Cancer

Jul 21, 2009

Current methods of detecting breast cancer suffer from low sensitivity, limited spatial resolution, or the need to use complicated and expensive radioisotope-based technologies. A new report from investigators at the Emory-Georgia ...

Self-Assembling Nanoparticles Image Tumor Cells

Jul 23, 2007

By taking advantage of the full range of ways in which molecules can interact with and bind to one another, a team of investigators at the Carolina Center of Cancer Nanotechnology Excellence has created nanoparticles that ...

Image-guided breast cancer therapy enabled by nanodrug

Oct 28, 2010

By combining an iron oxide nanoparticle, a tumor-targeting peptide, and a therapeutic nucleic acid into one construct, a team of investigators from the Massachusetts General Hospital and Harvard Medical School have created ...

Nanoparticles Designed for Dual-Mode Imaging

Dec 18, 2006

Nanoscale, inorganic fluorescent imaging agents such as quantum dots have become an important tool for researchers studying key biomolecules involved in cancer. At the same time, magnetic iron oxide nanoparticles are proving ...

Tracking tumor-targeting nanoparticles in the body

Oct 27, 2010

Though targeted nanoparticle-based imaging agents and therapeutics for diagnosing and treating cancer are making their way to and through the clinical trials process, researchers still do not have a good understanding of ...

Remote Magnetic Field Triggers Nanoparticle Drug Release

Nov 08, 2007

Magnetic nanoparticles heated by a remote magnetic field have the potential to release multiple anticancer drugs on demand at the site of a tumor, according to a study published in the journal Advanced Materials. Moreover, say th ...

Recommended for you

New nanodevice defeats drug resistance

4 hours ago

Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug treatment, tumors can grow back. A new nanodevice developed by MIT researchers can help overcome that by first blocking ...

Glass coating improves battery performance

5 hours ago

Lithium-sulfur batteries have been a hot topic in battery research because of their ability to produce up to 10 times more energy than conventional batteries, which means they hold great promise for applications ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.